Jenburkt Pharmaceuticals informs about unaudited financial results

28 Oct 2025 Evaluate
Jenburkt Pharmaceuticals has informed that it enclosed Standalone Unaudited financial results for the quarter and half year ended on 30th September, 2025.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

1110.90 60.40 (5.75%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×